Fanconi anemia (FA) is a hereditary chromosomal instability syndrome with cancer predisposition. Bone marrow failure resulting in pancytopenia is the main cause of death of FA patients. Diagnosis of FA is based on their cellular hypersensitivity to DNA crosslinking agents and chromosome breakages. Somatic complementation experiments suggest the involvement of at least eight genes in FA. The gene for complementation group A (FANCA) is defective in the majority of FA patients. We show here that mice deficient of Fanca are viable and have no detectable developmental abnormalities. The hematological parameters showed a slightly decreased platelet count and a slightly increased erythrocyte mean cell volume in mice at young age, but this did not progress to anemia. Consistent with the clinical phenotype of FA patients, both male and female mice showed hypogonadism and impaired fertility. Furthermore, embryonic fibroblasts of the knock-out mice exhibited spontaneous chromosomal instability and were hyper-responsive to the clastogenic effect of the crosslinker mitomycin C.
INTRODUCTION
Fanconi anemia (FA) is an autosomal recessive disorder characterized by aplastic anemia due to bone marrow failure, congenital abnormalities of the skeleton, kidney, skin and heart, and an increased risk for the development of leukemia and squamous cell carcinoma (1) . FA patients often show retarded growth and hypogonadism. Pancytopenia typically occurs during the first decade of life, usually starting with thrombocytopenia associated with macrocytic erythrocytes and elevated fetal hemoglobin (HbF), followed by neutropenia, and finally anemia. The pancytopenia is associated with reduced bone marrow cellularity. FA is also a genomic instability syndrome: patients' cells show chromosomal aberrations and are hypersensitive to DNA crosslinking agents. This in vitro phenotype has become the basis of FA diagnosis.
The clinical manifestations of FA are highly variable. Asymptomatic and severe cases may co-exist within a family. In addition to the clinical heterogeneity, FA also displays genetic heterogeneity. Fusion of cells from different patients show complementation of the crosslinker sensitivity suggesting that distinct genes are involved in this disorder. To date, eight complementation groups have been identified, designated FA-A to FA-H (2). Four FA genes (FANCA, FANCC, FANCG and FANCF) have been cloned (3) (4) (5) (6) (7) and two additional genes (FANCD and FANCE) have been mapped (8, 9) .
No correlation has so far been found between complementation groups, clinical phenotype and disease outcome. The cloning of the FA genes represented a breakthrough in the FA diagnosis, but has not yet shed light on the etiology of the disease. The four FA genes identified thus far did not show homology to other gene sequences in the databases. In addition, unlike other genes associated with genomic stability (XP, AT, BS, HNPCC), no homologs are found in simple organisms like yeast and bacteria (10) (11) (12) (13) (14) . Biochemical studies showed association of the FA proteins (15) (16) (17) , suggesting that they act in a complex. Complexes were mainly found in the cell nucleus. These data could suggest an evolutionarily novel pathway of FA genes in the maintenance of genomic integrity.
FA-A is the major FA complementation group, accounting for 66% of the patients worldwide (1). The corresponding gene, FANCA, was cloned in 1996 (4, 5) . This is a large gene consisting of 43 exons and coding for a 160 kDa protein. Mutation analyses in FA-A patients did not identify mutational hotspots (18, 19) .
Animal models are important tools in the understanding of human diseases. Analysis of mice defective in FA genes can give insight into the biological function of the genes and their role in the relevant biochemical pathways. Moreover, they may prove useful for testing potential therapies. We generated mice with a null mutation in the Fanca gene. The mutants show the expected cellular phenotype as well as impaired fertility but minor, if at all significant, hematological features of the disease.
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RESULTS

Generation of Fanca -/-mice
The targeted mutagenesis of the Fanca gene was performed by replacement of exons 4-7 by the lacZ-Neo fusion marker (Fig. 1A) . Introduction of the targeting construct into mouse embryonic stem (ES) cells yielded clones with the expected homologous recombination (Fig. 1B) . Two mouse lines were generated from independent ES cell clones. Chimeric males were used for germline transmission of the targeted Fanca allele. Genotyping was performed by PCR analysis (Fig. 1C) . Absence of FANCA protein expression in the mutant mice was confirmed (Fig. 1D) . Interbreeding of heterozygotes produced the expected proportion of homozygous mutant offspring. Fanca -/-mice appeared normal, without obvious congenital malformations or growth retardation.
Fanca -/-mice have impaired fertility
FA patients have reduced fertility. Therefore, we studied fertility in the Fanca mutant mice (Fig. 2) . Ten-to twelveweek-old Fanca -/-mice were bred with wild-type mice and followed over time. The Fanca -/-females showed a severe fertility defect; they stopped breeding between 10 and 21 weeks of age ( Fig. 2A) . The mean litter size was smaller than that of control litters (Fig. 2B) . Reduced fertility was also observed in males, although less severe. They reproduce for longer than the females, but after ∼20 weeks of age both the number and size of their litters declined precipitously, with the majority becoming completely infertile. However, occasionally some males regained reproductivity after a non-reproductive period of several months.
Gonadal abnormalities of Fanca -/-mice
Infertility was accompanied by striking abnormalities in the gonads, apparent in histological examination of 2.5-to 10-month-old mice. Hypogonadism was obvious for both sexes ( Fig. 3B and F) . The seminiferous tubules in mutant testes were atrophic with strongly reduced spermatogenesis ( Fig. 3D ) compared with control testes (Fig. 3C ). In addition, mutant testes showed hyperplasia of Leydig cells. Ovaries of Fanca -/-females have few or almost no follicles. The ovaries were composed mainly of interstitial cells (compare Fig. 3H and G). No other consistent congenital abnormalities were noticed in the mutant mice. Bone marrow of Fanca -/-mice showed no signs of hypoplasia and hematopoiesis appeared normal.
Hematological parameters
FA patients typically develop pancytopenia during childhood. We therefore performed periodic hematological measurements on Fanca -/-mice starting from 8 weeks of age. Fanca -/-mice showed no signs of obvious spontaneous anemia. Red blood cell count was normal both in the mutants and in the control groups. No significant difference was seen in the hemoglobin and hematocrit values between the Fanca mutants and controls. The platelet count was somewhat reduced in the knock-out group (Fig. 4 ) and the mean cell volume (MCV) of Fanca -/-mice was slightly higher, suggestive of macrocytic red cells. These features were seen in mice ∼20 weeks of age. However, as all other hematological parameters, including total erythrocyte counts and hemoglobin levels, are normal in Fanca -/-mice (data not shown) and, since no further decrease in the platelet counts was measured over the course of time, there is no indication of progressive anemia in these animals.
In mice, the spleen is an important alternative hematopoietic organ in addition to bone marrow. To enforce reliance on the bone marrow and in that way accelerate potential failure of this hematopoietic source, splenectomy was carried out in a group of animals. However, hematological analysis 2 months after splenectomy did not show signs of anemia (data not shown).
Flow cytometry analysis of bone marrow, spleen and thymus showed no consistent abnormalities of the B and T lymphocyte, erythrocyte, macrophage and granulocyte lineages in Fanca -/-mice of 6 weeks to 10 months of age (data not shown). Fetal hemoglobin expression in adult Fanca -/-mice, assayed by gel electrophoresis, was not elevated (data not shown).
May-Gruenwald-Giemsa stained blood smears were made and white blood cells were analyzed and counted. No aberrant morphology was noted and white blood cell numbers (lymphocytes, granulocytes and monocytes) were similar in the three genotypes.
Altogether, these data suggest that Fanca -/-mice exhibit some minor hematological deviations characteristic of FA patients during the initial anemic phase. However, in contrast to FA patients, Fanca -/-mice do not develop progressive anemia, at least not within the first 12 months of life, so that the biological significance of these observations remains unclear.
Fanca -/-cells show the characteristic FA DNA crosslinkersensitive phenotype
Mouse embryonic fibroblasts (MEFs) were analyzed for DNA crosslinker sensitivity in a mitomycin C (MMC) growth inhibition assay. Fanca -/-primary MEFs are more sensitive to MMC than wild-type and heterozygous MEFs. Whereas the IC50 for the control cells is ∼30 ng/ml, 50% of proliferation was inhibited in Fanca -/-MEFs at ∼3 ng/ml MMC (Fig. 5A) . The increased MMC sensitivity was also observed in Fanca -/-post-crisis MEFs and Concanavalin-A-stimulated splenocytes (data not shown). Another diagnostic parameter of FA is chromosome breakages. Hence, metaphase spreads from primary MEFs were analyzed for chromosomal damage (Fig. 5B) . In the absence of MMC, 4% of wild-type MEFs showed aberrations whereas 22% of the Fanca -/-cells presented spontaneous chromosomal damage (Fig. 5B, white bars) . Treatment with MMC induced mild chromosomal damage in the Fanca +/+ cells, and 78% of the metaphase spreads showed no abnormalities. In contrast, MMC treatment caused severe chromosomal damage in Fanca -/-cells. The majority of cells contained >10 aberrations (Fig. 5B, black bars) . The heterozygous cells showed an intermediate level of chromosomal aberrations (data not shown), as described for some human carriers.
DISCUSSION
FA patients exhibit extreme clinical heterogeneity. The characteristic hypersensitivity of FA cells to DNA crosslinking agents has been introduced as a reliable indicator for this disorder. Mice mutated in the Fanca gene show this FA cellular phenotype and are therefore useful models in which to study this aspect of the disease. Skeletal abnormalities, observed in a large proportion of FA patients were not found in Fanca -/-mice following radiological examination (data not shown).
FA patients show severe depletion of bone marrow stem cells resulting in aplastic anemia. Mice, however, have a very resilient hematopoietic system. Our attempts to make anemic mice by mutational disruption of the Fanca gene has not resulted in a model of this aspect of the human disease: the Fanca -/-mice showed some minor hematological parameters of FA patients. Attempts to stress further the mouse hematopoietic system by splenectomy did not result in anemia or reduced blood cell counts. In this respect Fanca -/-mice behave similar to Fancc -/-mice (20, 21) , which also failed to show anemia following disruption of the Fancc gene. However, loss of FANCC protein results in a reduced hematopoietic stem cell repopulation ability (22) , and anemia in Fancc -/-animals can be induced by treatment of the animals with DNA crosslinking agents (23) .
FA male patients often display hypogonadism and reduced sperm count, and rarely produce offspring. Although pregnancies of FA female patients have been reported in a few cases, premature menopause has also been described, starting as early as 26 years (24) . In mice lacking Fanca expression, female infertility is more severe. Young female mice are able to reproduce, although they have smaller litters. However, these mice cease breeding at an early age. Histological analysis showed almost no mature follicles. Nevertheless, the presence of degenerated oocytes and the normal uterus morphology suggest that previous hormonal stimulation occurred, indicating a more or less normal functional development of the reproductive system initially. This may be comparable to premature menopause in FA patients. Endocrine studies in this report are limited to staining of pituitary glands for folliclestimulating hormone and leutinizing hormone. No consistent differences between the genotypes was observed. Hypogonadism and a reduced spermatogenesis with increased number of Leydig cells was observed in a male FA patient (25) . The histological picture in a 15-year-old male patient is described as a 'Sertoli-cell-only' defect and very few spermatogonia were observed in a post mortem examination of the testis (25) . The reduction in the number of spermatogonia seems more severe in humans than in our Fanca -/-mice, where seminiferous tubules with apparently normal spermatogenesis are present. FA is a member of a group of different diseases, characterized by defects in caretaker genes (26) which safeguard genomic integrity. Mutations in several caretaker genes are associated with defects in fertility. The evidence points to a role of ATM, MLH1, PMS2 and BLM proteins in meiosis (27) (28) (29) (30) . BLM and MLH1 proteins are found to localize in the synaptonemal complex. Fanca -/-mice also clearly show defects in fertility. Histology of mutant testis showed seminiferous tubules with normal spermatogenesis next to abnormal tubules with strongly reduced spermatogenesis. This observation is suggestive of a role of FANCA proteins in maintenance of adequate number of spermatogenic stem cells. Localization studies of FANCA protein in spermatogonia and synaptonemal complexes, Sertoli and Leydig cells will be helpful in understanding the precise function of FANCA protein in spermatogenesis.
MATERIALS AND METHODS
Construction of the Fanca gene-targeting vector
An 11 kb EcoRI genomic fragment containing exons 3-12 of the Fanca gene from the 129Ola strain was subcloned into pBRMG, a modified pBR322 vector (generously supplied by M. Giovannini). Partial BamHI digestion was performed to delete the 4.4 kb fragment containing exons 4-7 and the restriction overhangs were filled in with dATP and dGTP. The 6.7 kb SalI cassette containing the second intron from the Engrailed gene, a splice acceptor site, an IRES, the lacZ-Neo fusion gene and the SV40 polyadenylation signal was isolated from the pGT1.8IresBgeo plasmid (B. Skarnes), partially filled in with dTTP and dCTP and ligated to the Fanca construct.
ES cell targeting and generation of Fanca -/-mice
The targeting construct was isolated from the vector by NotI digestion and electroporated into E14 ES cells derived from the 129Ola strain. Genomic DNA from clones surviving G418 selection were isolated, digested with XbaI or NheI, and analyzed with the 5′ or 3′ probes on Southern blots. Subsequent hybridizations of the same blots with internal probes from the lacZ-Neo cassette confirmed the homologous recombination in the clones. Two independent ES clones with normal karyotype were injected into blastocysts from the C57Bl/6 strain and the resulting chimeric males were bred with FVB females and germline transmission was obtained. Heterozygous F 1 mice were intercrossed to produce homozygous mutant mice. Genotype was determined by PCR analysis on mouse tail DNA with primer sets for the endogenous exon 4-6 allele (primers GGATCAGGCCTCGAGGCTGG and TGCA-GTAGCTCCTGTAGGCT, ∼750 bp) and for the recombinant Neo allele (GACTGGGCACAACAGACAATCGGCT and TGATATTCGGCAAGCAGGCATCGCC primers, 523 bp).
FANCA protein expression was analyzed in cell lysate from mouse tissues or MEFs by immunoprecipitation and western blot with antiserum directed against the GST-FANCA fusion protein (amino acids 1-454) (31) .
Hematological analysis
Peripheral blood was collected by orbital puncture, with EDTA as an anticoagulant. Measurements of blood cell counts, hemoglobin and hematocrit levels, and the derived mean MCV, mean cell hemoglobin and mean cell hemoglobin concentration values were performed on a Sysmex K-4500 machine (Goffin-Meyvis, Tiel, The Netherlands).
Histological analysis
Mice were sacrificed and isolated organs were fixed in 4% paraformaldehyde in PBS, pH 7.8, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. These include testis, ovary, kidney, liver, spleen, intestines, thymus, heart, lungs, extremities, salivary gland, eye, brain, pituitary gland and bone marrow.
MMC growth inhibition assay
MEFs were derived from 14 day post coitum embryos and seeded in quadruplicate in 96-well microtiter plates at a density of 500 cells/well in Dulbecco's modified Eagle's medium with glutamate (Gibco BRL) containing 10% fetal bovine serum supplemented with sodium pyruvate and penicillin/streptomycin. MMC was added in a dilution series of 0-640 ng/ml. Cells were incubated for 5 days at 37°C in a 5% CO 2 incubator. Plates were frozen at -80°C. Nucleic acid quantification was performed with a proprietary dye (CyQUANT; Molecular Probes) and subsequently analyzed by an ELISA plate reader according to the manufacturer's directions.
MMC-induced chromosome breakage analysis
MEFs were incubated for 48 h in the absence or presence of 50 nM MMC. For each culture, 50 metaphase spreads were analyzed for chromosomal abnormalities, which included both chromosome and chromatid-type aberrations.
